Literature DB >> 8500230

Biochemical consequences of 5-fluorouracil gastrointestinal toxicity in rats; effect of high-dose uridine.

J Kralovanszky1, N Prajda, S Kerpel-Fronius, T Bagrij, E Kiss, G J Peters.   

Abstract

Selective protection of the normal host tissues from the toxic effects of anticancer agents would allow the use of higher, probably more effective, doses of the drugs. It has been demonstrated that delayed high-dose uridine administration after 5-fluorouracil decreases the extent of myelosuppression and causes faster regeneration of the bone marrow. We studied the biochemical consequences of the gastrointestinal toxicity caused by 5-fluorouracil and the potential of high-dose uridine treatment to influence these adverse effects. 5-Fluorouracil caused dose-related decreases in the biochemical parameters (thymidine kinase, sucrase, maltase, alkaline phosphatase) selected as early markers of the impaired metabolic activity of the intestinal mucosa. The nadir of the biochemical changes was reached between 24 h and 72 h after 5-fluorouracil treatment, and complete regeneration of the mucosa took 6-7 days. Delayed high-dose uridine administration failed to mitigate the severity of the gastrointestinal damage that ensued after 5-fluorouracil treatment, but caused significantly earlier regeneration of the mucosa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500230     DOI: 10.1007/BF00685843

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  23 in total

1.  Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine.

Authors:  J A Houghton; P J Houghton; R S Wooten
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

Review 2.  Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators.

Authors:  G Weckbecker
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

3.  Side effects of a cytostatic treatment on the gastrointestinal tract.

Authors:  G Hartwich
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1974-04

4.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

5.  5-fluorouracil given once weekly: comparison of intravenous and oral administration.

Authors:  J R Bateman; R P Pugh; F R Cassidy; G J Marshall; L E Irwin
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

6.  Correlation between the histological changes and glucose intestinal absorption following a single dose of 5 fluorouracil.

Authors:  A C Roche; J C Bognel; C Bognel; J J Bernier
Journal:  Digestion       Date:  1970       Impact factor: 3.216

7.  Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP).

Authors:  J Kralovánszky; N Prajda; S Kerpel-Fronius; F Gál; F Kiss
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Uridine rescue from the lethal toxicity of 5-fluorouracil in mice.

Authors:  P Klubes; I Cerna; M A Meldon
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  High-dose 5-fluorouracil with delayed uridine "rescue" in mice.

Authors:  D S Martin; R L Stolfi; R C Sawyer; S Spiegelman; C W Young
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

10.  In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.

Authors:  G J Peters; J van Dijk; E Laurensse; C J van Groeningen; J Lankelma; A Leyva; J C Nadal; H M Pinedo
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

View more
  2 in total

1.  Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation.

Authors:  D M Pritchard; A J Watson; C S Potten; A L Jackman; J A Hickman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

2.  [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study.

Authors:  W G E Direcks; S C Berndsen; N Proost; G J Peters; J Balzarini; M D Spreeuwenberg; A A Lammertsma; C F M Molthoff
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.